10X Genomics Inc
TXG20.460USD
+1.170+6.07%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
2.59BMarket Cap
LossP/E TTM
10X Genomics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
610.78M
-1.28%
EPS(YoY)
-1.52
30.36%
Analyst Rating
HOLD
2026-01-07
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its total revenue reached 610.78M, with a year-on-year change of -1.28%.
What is the Earnings Per Share (EPS) of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.516, with a year-on-year change of 30.36%.
What is the net income of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its net income was -182.63M, with a year-on-year change of 28.41%.
What is the net margin of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its net profit margin was -29.90%, with a year-on-year change of 27.48%.
What is the gross margin of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its gross margin was 67.91%, with a year-on-year change of 2.65%.
What is the debt-to-asset ratio of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its Return on Equity (ROE) was -25.17%, with a year-on-year change of 23.69%.
What is the Return on Assets (ROA) of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its Return on Assets (ROA) was -19.39%, with a year-on-year change of 24.22%.
What is the operating profit of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its operating profit was -192.46M, with a year-on-year change of 1.28%.
What are the current assets of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its current assets were 584.39M, with a year-on-year change of -1.95%.
What are the total assets of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its total assets of 10X Genomics Inc were 918.64M, with a year-on-year change of -4.82%.
What are the total liabilities of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its total liabilities of 10X Genomics Inc were 208.50M, with a year-on-year change of -6.96%.
What is the total equity of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its total equity of 10X Genomics Inc was 710.13M, with a year-on-year change of -4.17%.
What is the net operating income of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its net operating income of 10X Genomics Inc was -182.63M, with a year-on-year change of 28.41%.
What is the net investment of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its net investment of 10X Genomics Inc was -32.63M, with a year-on-year change of -124.44%.
What is the net financing of 10X Genomics Inc?
According to 10X Genomics Inc's FY2024 earnings report, its net financing of 10X Genomics Inc was 10.91M, with a year-on-year change of -20.16%.
